(Q38416281)
Statements
1 reference
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD. (English)
1 reference
A M Kirsten
1 reference
K Förster
1 reference
E Radeczky
1 reference
A Linnhoff
1 reference
B Balint
1 reference
H Watz
1 reference
H Wray
1 reference
L Salkeld
1 reference
M Cullberg
1 reference
B Larsson
1 reference
11 February 2015
1 reference
1 reference
31
1 reference
36-41
1 reference
Identifiers
1 reference
1 reference